Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme

Showing 1901 to 1950 of 2061

TitleReference numberPublishedLast updated
Transaxial interbody lumbosacral fusion for severe chronic low back painIPG620
Transcatheter aortic valve implantation for aortic stenosisIPG586
Transcatheter endovascular closure of perimembranous ventricular septal defectIPG336
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitationIPG730
Transcatheter tricuspid valve leaflet repair for tricuspid regurgitationIPG731
Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stentingIPG561
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroidsIPG689
Transcranial direct current stimulation (tDCS) for depressionIPG530
Transcranial magnetic stimulation for auditory hallucinationsIPG680
Transcranial magnetic stimulation for obsessive-compulsive disorderIPG676
Transcranial magnetic stimulation for treating and preventing migraineIPG477
Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic painIPG632
Transcutaneous electrical neuromuscular stimulation for urinary incontinenceIPG735
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraineIPG740
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDIPG748
Transcutaneous microwave ablation for severe primary axillary hyperhidrosisIPG601
Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adultsIPG634
Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraineIPG552
Transient loss of consciousness ('blackouts') in over 16sCG109
Transient loss of consciousness ('blackouts') in over 16sQS71
Transilluminated powered phlebectomy for varicose veinsIPG37
Transition between inpatient hospital settings and community or care home settings for adults with social care needsNG27
Transition between inpatient hospital settings and community or care home settings for adults with social care needsQS136
Transition between inpatient mental health settings and community or care home settingsNG53
Transition between inpatient mental health settings and community or care home settingsQS159
Transition from children's to adults' servicesQS140
Transition from children's to adults' services for young people using health or social care servicesNG43
Translaryngeal tracheostomyIPG462
Transmyocardial laser revascularisation for refractory angina pectorisIPG301
Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancyIPG484
Transperineal biopsy for diagnosing prostate cancerDG54
Transperineal template biopsy and mapping of the prostateIPG364
Transpupillary thermotherapy for age-related macular degenerationIPG58
Transurethral electrovaporisation of the prostateIPG14
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancerIPG656
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG625
Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG770
Transvaginal laser therapy for stress urinary incontinenceIPG696
Transvaginal laser therapy for urogenital atrophyIPG697
Transvaginal mesh repair of anterior or posterior vaginal wall prolapseIPG599
Transvenous obliteration for gastric varicesIPG751
Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA976
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)TA879
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
Trastuzumab for the treatment of HER2-positive metastatic gastric cancerTA208
TraumaQS166
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)TA945

Results per page

  1. 10
  2. 25
  3. 50
  4. All